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DCs are a heterogeneous group of professional 
APCs. Upon activation, DCs migrate to second-
ary lymphoid organs and present antigen to their 
cognate T cells for the induction of adaptive 
immune responses (Banchereau and Steinman, 
1998). In human cancer, there is now clinical 
evidence suggesting that the induction or activa-
tion of CD8+ T cells can contribute to the arrest 
of tumor growth and increased patient survival. 
In principle, targeting tumor antigens to DCs 
may enhance protective CD8+ T cell responses 
due to the ability of DCs to cross-present exog-
enous antigens (Segura and Villadangos, 2009). 
In cross-presentation, exogenous proteins are 
internalized, processed, and presented to CD8+  
T cells by MHC class I molecules. Specific DC 
populations (CD8+/CD103+ DCs in the mouse, 
blood CD141+ DCs in humans) are thought 
to be particularly adept in cross-presentation of 
antigens compared with others (Bachem et al., 
2010; Jongbloed et al., 2010; Poulin et al., 2010; 
Romani et al., 2010).
Studies examining the DCs in the skin, 
the main targets of vaccines, showed that healthy 
human skin displays multiple DC populations:
Langerhans cells (LCs) in the epidermis and in-
terstitial DCs in the dermis consisting of CD1a+ 
and CD14+-expressing DCs (Lenz et al., 1993; 
Nestle et al., 1993; Klechevsky et al., 2008; 
Klechevsky, 2013). CD141 was recently re-
ported to mark a population within the dermal 
CD1a(dim) DCs and is also known to be a marker 
expressed on dermal CD14+ DCs (Chu et al., 
2012; Haniffa et al., 2012). We, and others, have 
previously shown that human epidermal LCs 
are more efficient at priming naive CD8+  
T cells into potent cytotoxic T cells (CTLs) com-
pared with the dermal CD14+ DCs (Ratzinger 
et al., 2004; Klechevsky et al., 2008, 2009; Polak 
et al., 2012). Dermal CD14+ DCs were later 
shown to induce regulatory T cells (Chu et al., 
2012) and impaired priming of CTLs due to 
their IL-10 production and the expression of 
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Characterization of functionally distinct dendritic cell (DC) subsets in mice has fueled 
interest in whether analogous counterparts exist in humans. Transcriptional modules of 
coordinately expressed genes were used for defining shared functions between the species. 
Comparing modules derived from four human skin DC subsets and modules derived from the 
Immunological Genome Project database for all mouse DC subsets revealed that human 
Langerhans cells (LCs) and the mouse XCR1+CD8+CD103+ DCs shared the class I–mediated 
antigen processing and cross-presentation transcriptional modules that were not seen in 
mouse LCs. Furthermore, human LCs were enriched in a transcriptional signature specific to 
the blood cross-presenting CD141/BDCA-3+ DCs, the proposed equivalent to mouse CD8+ 
DCs. Consistent with our analysis, LCs were highly adept at inducing primary CTL responses. 
Thus, our study suggests that the function of LCs may not be conserved between mouse and 
human and supports human LCs as an especially relevant therapeutic target.
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mouse and human LCs, we performed a cross-species com-
parison using co-expression module analysis between human 
cutaneous DCs and mouse DCs (Fig. 1). This type of analysis 
groups genes together based on the similarity of their changes 
between subsets. We applied weighted gene co-expression 
network analysis (WGCNA) to define conserved transcrip-
tional modules (Langfelder and Horvath, 2008). This compu-
tational approach is based on the idea that the probability for 
multiple transcripts to follow a complex pattern of expression 
across dozens of conditions only by chance is low. Thus, 
groups of genes that segregate together across many different 
conditions should constitute coherent and biologically mean-
ingful transcriptional units. Data from multiple DC subsets 
were analyzed to define coordinately expressed transcripts 
that were grouped together to define a module. Specifically, 
the degree of “closeness” between all pairs of genes was de-
fined by Pearson’s correlation coefficients. Modules were 
then compared between species. Strong correlations thus iden-
tified genes that have the most similar expression patterns 
across the samples in the dataset.
Construction of mouse DC transcriptional modules
We took advantage of the large compendium of murine DC 
expression data that are available through the Immgen data-
base. Overall, we used the WGCNA algorithm on 116 sam-
ples encompassing 36 DC subpopulations (Langfelder and 
Horvath, 2008) to construct and define modules. For each 
module, representative eigen genes could be defined that re-
flect the collective behavior of each module. Using this ap-
proach, we were able to define each cell type by the behavior 
of 16 independent modules (Fig. 2 A and Table S1). Each 
module represented specific components from 19 different 
pathways (Fig. 2 B). Modules showed a large degree of cell 
specificity in their expression patterns (Fig. 2 A). For exam-
ple, expression of module Mm2 was enriched in the lymph 
node migratory populations of DCs, expression of module 
the inhibitory immunoglobulin-like transcript (ILT) recep-
tors (Banchereau et al., 2012a,b).
Although cellular heterogeneity has been studied exten-
sively in the immune system, understanding the biological 
functions of various DC subsets in humans is underdeveloped 
relative to the mouse. The alignment of DC subsets between 
mice and humans is of key importance in correlating human 
studies with mouse in vivo experiments. Transcriptional pro-
filing is a powerful tool that has been used to examine several 
aspects of antigen presentation identity (Crozat et al., 2010b; 
Gautier et al., 2012). These and other studies used gene- 
centric, fold-change-based approaches to focus on the impli-
cations of expression differences between individual genes. 
More recent studies have integrated methods to harness the 
power of combining datasets and the coordinate expression 
of genes across cell types and species (Crozat et al., 2010b). 
These studies have helped identify pathways related to disease 
(Chaussabel et al., 2008; Berry et al., 2010), hematopoietic 
lineage differentiation (Ng et al., 2009; Novershtern et al., 
2011) and T cell differentiation state (Doering et al., 2012).
In this study, we used a transcriptional profiling approach 
combined with network-based computational analysis and 
functional assays as a tool for investigating the functional sim-
ilarities that might exist between human skin DCs and the 
mouse cross-presenting CD8+/CD103+ DC subsets.
RESULTS
Generation of coherent functional  
modules of co-expressed genes
Determining the homology between the murine and the 
human DC systems is an important unresolved issue, not only 
for the appropriate translation of mouse data for clinical use, 
but also to develop better preclinical models for human disease. 
One of the main controversies in the DC literature is the con-
tribution of LCs in human versus mouse immunity (Romani 
et al., 2010). To reconcile the functional differences between 
Figure 1. Experimental strategy. The research strategy showing the computational and functional analyses that are involved in identifying and vali-
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significant enrichment in genes involved in antigen cross-
presentation and related pathways (Fig. 2 B). This module 
was expressed in thymic and small intestine CD103+CD11b 
DCs, suggesting that these cell types are particularly efficient 
in cross-presentation among murine DCs. Importantly, ex-
pression of XCR1, the definitive marker of cross-presenting 
cell types in mice (Bachem et al., 2010; Crozat et al., 2010a), 
was also strongest in these cell types (Fig. 2 A, bottom). Fur-
thermore, these cell types, uniquely expressed CD8 and 
CD103 (Fig. 2 A, bottom). Thus, transcriptional modules can 
be used to generate coherent transcriptional and functional 
units representing distinct subpopulations.
Construction of human skin DC transcriptional modules
To investigate the functional relationship between human DC 
systems, we analyzed human skin DCs (17 samples spanning 
four major skin DC subsets) in a manner similar to the approach 
Mm3 was enriched in pDCs, and expression of Mm1 was 
specific to thymic and CD103+CD11b small intestine sub-
populations, whereas expression of Mm6 consisted of genes 
whose regulation was shared between the CD4+ DCs and 
CD103CD11b+ skin draining lymph node. Along the same 
lines, module Mm16 included genes specific for CD103 
CD11b+ DCs. Overall the pattern of all 16 subsets was dis-
tinct for each cell type.
We characterized each module functionally by compar-
ing components of the module against a database of anno-
tated canonical pathways (Reactome; Matthews et al., 2009). 
A functional relationship between multiple components was 
clearly observed in several modules (Fig. 2 B). For instance, 
module Mm4 is enriched in genes involved in fatty acid 
metabolism, which is a distinct feature of murine pDCs. In 
contrast, TCA cycle genes are enriched in Mm1, which is 
characteristic of thymic DCs. Importantly, Mm1 also showed 
Figure 2. Gene co-expression network 
analysis identifies conserved transcrip-
tional modules in mouse and human skin 
DCs. (A) Transcriptional landscape of mouse 
DCs described in 16 modules (Mm1–Mm16). 
Expression values for eigen genes correspond-
ing to each module are shown, as well as the 
expression of xcr1, cd8a, and (Itgae) CD103  
as identifiers of cross-presenting subsets 
(bottom). (B) Enrichment of annotated path-
ways in individual murine transcriptional mod-
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Figure 3. Characterization of human epidermal and dermal DCs. (A) Epidermal- and dermal-resident DCs were allowed to migrate from their  
respective tissues and were harvested after 2 d. The cells were stained with CD1a and CD14 mAbs, and analyzed by flow cytometry. Epidermal sheets 
yielded CD1ahiCD14 cells (LCs; blue). Dermis yielded two distinct populations: CD1aCD14+ cells (dermal CD14+ DCs; Red) and CD1a(dim)CD14 cells  
(dermal CD1a(dim) DCs). Dermal CD1a(dim)Langerin(neg) DC population was further divided into two major sub populations based on CD141 expression (dark 
and light purple). 1 representative out of at least 30 donors analyzed. (B) Principal component analysis (PCA) of microarray data describing the relationship 
between the distinct human skin DC subsets: LCs, dermal CD1a(dim)CD141, dermal CD1a(dim)CD141+, and dermal CD14+ DCs. Plot shows the first two prin-
cipal components. Data of 3–4 donors from each DC subset are graphed. (C, top) Expression values for nine eigen genes describing transcriptional mod-
ules that were identified for four human skin DC subset through Gene Coexpression Network Analysis. (C, bottom) Conservation analysis (through Fisher’s 
exact test) between human and mouse transcriptional modules is shown. Higher red color intensity signified a greater significant overlap between the 
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Using modules to map transcriptional correlates  
between human dermal DCs and mouse DCs
To determine whether modules overlap between human 
skin and murine DC subsets, we used Fisher’s exact test to 
measure the similarity between two modules. We found 
that the composition of several modules were highly similar 
between murine and human DC systems (Fig. 3 C, bottom; 
and Table 1).
We then assessed the functional relationship between mouse 
DCs and individual human skin DC subsets by comparing 
similarities in expression modules. We found that the module 
expressed in human dermal CD14+ DCs (Hu4) was most simi-
lar to the module expressed in murine CD103CD11b+ cells 
(Mm16; Fig. 3 C). A closer examination showed that these cells 
also shared an enrichment in genes involved in interferon sig-
naling (RIGI and the MDA5), as well as genes involved in the 
response to cytosolic Ca2+.
The module expressed in human dermal CD141+ skin 
DCs (Hu1) was conserved with mouse module Mm6. Al-
though mouse Mm6 did not correspond to any single mouse 
DC subtype, it included genes that were enriched in the mouse 
LanghighCD103CD11b+ DCs and the CD4+ DCs from skin 
draining lymph nodes (Fig. 2 A). Both mouse CD11b+ and 
CD4+ DCs are of similar origin and are BATF3 independent 
(Hildner et al., 2008). We found that they share common fea-
tures with the human dermal CD141+ DCs (Fig. 3 C). Thus, 
human dermal CD141+ DCs and CD14+ DCs corresponded 
to the mouse CD4+ and CD11b+ DCs, respectively.
Using modules to map transcriptional analogies  
between epidermal LCs and mouse DCs
Next, we assessed the relationship between human LCs and 
mouse DCs using a similar approach. We found that the 
we used for the mouse data. Our goal was to identify modules 
of coordinately expressed human DC transcripts and compare 
them to the modules that we identified in mouse.
As we have previously reported, epidermal sheets yielded 
CD1ahiCD14HLA-DR+ cells expressing Langerin (CD207), a 
marker of LCs (Fig. 3 A; Klechevsky et al., 2008). Dermal sheets 
yielded two major populations: HLA-DR+CD1aCD14+ cells 
(dermal CD14+ DCs) and HLA-DR+Langerin(neg)CD1a(dim)CD 
14 cells (dermal CD1a(dim) DCs; Fig. 3 A and Fig. S1 A, popula-
tion IV). The latter can be further subdivided into 2 populations 
based on CD141 expression (Fig. 3 A, right). Studies performed 
with 32 skin samples revealed that LCs represented 36% of all 
the DCs that were isolated. Dermal CD1a(dim) DCs represented 
54% of the viable lineage-negative migrating FSChiSSChiHLA-
DR+ cells of which 3% expressed CD141. Dermal CD14+ DCs, 
the second major dermal DC population represented 10% of the 
migrating FSChiSSChiHLA-DR+ cells (Fig. S1 B).
RNA was purified and expression analysis was performed 
using microarrays. Principal Component Analysis (PCA), a 
clustering approach widely used for population stratification, 
showed a clear separation between individual DC subtypes 
(Fig. 3 B). Gene co-expression analysis was used to identify 
the major transcriptional modules expressed in the different 
human skin DC populations. Nine major modules were 
identified (Hu1-Hu9; Fig. 3 C, top; and Table S2). Although 
the expression of a single module could define an individual 
cell type, we also identified two modules (i.e., Hu3 and Hu6) 
that were shared between two human skin DC popula-
tions. Module Hu3 was shared between LCs and dermal 
CD1a(dim)CD141 DCs, whereas Hu6 was shared between 
LCs and dermal CD14+ DCs. Thus, human skin DC subsets 
could be characterized based on transcriptional modules formed 
by coordinate gene expression.
channel, green), and either PSME1, Sec61a, or TAP2 (AF647 channel, red) as stated in the Materials and methods section. (left) Staining was observed in 
three channels corresponding to DAPI, AF488, or AF647 and co-localization between AF488 and AF647 channels was observed in the merged picture. 
Pictures show one representative z position. DCs expressing PSME1, Sec61a, or TAP2, (co-localization between AF488 and AF647 channel) are highlighted 
in white squares. (right) 93 numerical zoom on highlighted DCs is shown and white arrows show co-localization between Langerin and markers of inter-
est. Bar, 100 µm. Representative images out of six independent experiments done with four different donors.
 
Table 1. The number of genes that are shared between each human and mouse transcriptional module.
Genes Mouse 701 531 248 157 168 42 98 78 75 92 84 51 49 45 59 40
Human Module 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
312 1 72 60 37 23 16 23 16 16 13 7 3 5 4 7 7 3
794 2 311 142 62 53 49 8 25 19 19 15 32 11 20 6 17 5
494 3 124 157 34 25 28 3 18 19 18 20 17 9 7 8 6 1
408 4 75 63 61 27 39 1 19 4 13 25 11 12 5 12 16 25
90 5 13 14 17 5 8 2 6 2 0 6 2 4 1 1 6 3
192 6 75 40 13 9 9 2 5 5 6 1 10 5 5 3 3 1
139 7 17 41 10 10 10 0 6 10 6 12 3 4 4 4 2 0
55 8 6 8 8 5 7 2 1 2 0 5 2 1 1 4 1 2
34 9 8 6 6 0 2 1 2 1 0 1 4 0 2 0 1 0
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Human LCs express markers of the mouse  
CD8+/CD103+ DCs
To confirm our transcriptomic analysis showing potential 
function overlap between human LCs and mouse CD8+/
CD103+ DCs, we assessed using flow cytometry, the expres-
sion of several surface receptors that are specifically expressed 
on the latter. Indeed, CD24, a marker expressed on mouse 
dermal Langerin+CD103+ DCs, was also detected on human 
LCs, but not on any other skin DC subset. Sirp, a marker 
that is expressed on mouse macrophages, CD8CD11b+ 
DCs, and mouse LCs, was detected on the dermal CD14+ 
DCs, but not on human LCs (Fig. 4 A). Moreover, human 
LCs expressed high amounts of BTLA (Fig. 4 A), a marker 
that is selectively expressed by mouse CD8+ DCs and their 
tissue counterparts, CD103+CD11b DCs (Han et al., 2004b). 
Dermal CD1a(dim)CD141 DCs also expressed moderate 
amounts of BTLA in comparison to dermal CD1a(dim)CD141+ 
DCs and dermal CD14+ DCs that expressed low to undetect-
able levels of BTLA (Fig. 4 A). Whereas mouse LCs express 
CD11b, human dermal CD1a(dim) DCs and dermal CD14+ 
DCs, but not human LCs, expressed high-to-intermediate 
levels of CD11b (Fig. 4 A). All skin DC populations ex-
pressed CD11c; however, the epidermal LCs expressed 
lower levels compared with the dermal subsets (Fig. 4 A). 
Overall, consistent with our predictions based on our modu-
lar analysis, human LCs displayed a greater similarity to the 
mouse CD11bCD8+/CD103+ DCs than to mouse LCs, 
whereas dermal CD1a(dim)CD141+ and dermal CD14+ DCs 
displayed similar markers as the mouse CD11b+CD8/
CD103 DC subsets.
Human LCs are enriched with genes associated  
with cross-presentation and migratory capacity
To further confirm our analysis suggesting that LCs function in 
cross-presentation, we compared the gene expression profile 
human LC-specific module, Hu2 was most similar to the 
murine cluster, Mm1, a module that was most highly en-
riched in thymic DCs and in the CD103+CD11b small in-
testine DCs (Fig. 2 A and 3 C). As shown in Table 1, 311 
genes were shared between the human and mouse modules 
Hu2 and Mm1 and are expressed in the cross-presenting DC 
subsets in both species: in the mouse CD8+CD103+ DCs 
and in human LCs. Using the hypergeometric test and the 
MSigDB database, we found that this cross-species signature 
(provided in Table S3) was significantly enriched for path-
ways of antigen processing and cross presentation, as well as 
in related pathways including the ER phagosome pathway 
(Table 2 and Tables S4 and S5). Genes such as PSME1, 
SEC61a, and TAP2 that are functionally related to the cross-
presentation pathways, as we confirmed by tissue staining, 
were highly expressed in LCs before their migration out of 
the skin (Fig. 3 D). In addition, pathways related to tricar-
boxylic acid (TCA) cycle, metabolism, cell cycle, and mRNA 
regulation, as well as components of the cross-presentation 
machinery, i.e., the ER phagosome pathway, were shared 
(Table 2). Thus, the cross-presenting cell types in mice and 
humans share common metabolic, cell cycle, and regulatory 
genes in addition to actual antigen processing and presenta-
tion machinery.
Interestingly module Hu3 that corresponded to the mouse 
module Mm2 contained interferon-related genes and was 
also shared between human LCs and the CD141 popula-
tion. Importantly, we did not detect any overlap of modules 
between mouse and human LCs, suggesting that they are 
functionally dissimilar. Compared with other DC subtypes 
in the skin, human LCs were mostly enriched in expressed 
genes that are annotated as involved in cross-presentation and 
the expression of this set of genes was most similar to mouse 
CD8+ thymic DCs. This suggested that these two cell types 
share a similar role in initiating primary responses.
Table 2. Canonical pathway enrichment of shared genes
Gene set name No. genes in 
gene set (K)
No. genes in 
overlap (k)
k/K P-value
TCA cycle and respiratory electron transport 141 28 0.1986 6.66 × 10 33
VIF mediated degradation of apobec3g 52 16 0.3077 1.04 × 1022
Class I MHC mediated antigen processing presentation 251 25 0.0996 9.39 × 1022
Antigen processing ubiquitination proteasome degradation 212 23 0.1085 5.87 × 1021
Proteasome 48 14 0.2917 1.18 × 1019
ER phagosome pathway 61 14 0.2295 5.09 × 1018
Cell cycle mitotic 325 24 0.0738 6.79 × 1018
Cell cycle 421 26 0.0618 2.22 × 1017
Antigen processing cross presentation 76 14 0.1842 1.42 × 1016
Cross presentation of soluble exogenous antigens endosomes 48 12 0.25 4.02 × 1016
Metabolism of mRNA 284 20 0.0704 1.00 × 1014
Regulation of_mRNA stability by proteins that bind au rich elements 84 13 0.1548 1.90 × 1014
Enrichment (evaluated by hypergeometric test) of annotated canonical pathways among the genes that are shared between mouse module (Mm)1 and Human module (Hu)2 
and which are enriched in the mouse CD8+CD103+ cross-presenting DCs and human LCs, respectively. The list of these annotated genes (311) is provided in Table S3 and the 








niversity In St. Louis Libraries user on 07 D
ecem
ber 2019
JEM Vol. 212, No. 5
Article
749
shown in Fig. 5 B, the human LC-specific signature was 
enriched in the blood CD141+ DCs.
Next, in an unbiased approach, we performed an analysis 
to identify the enrichment of previously annotated gene sets 
in skin DCs. GSEA analysis (Subramanian et al., 2005) con-
firmed that LCs were significantly enriched (P < 103) in ca-
nonical pathways of antigen processing and cross-presentation 
(Fig. 5 C), as well as eight other pathways that function as part 
of the cross-presentation machinery compared with other 
skin DC subsets, (Fig. S3 B). Finally, the LC-specific signature 
(Fig. S3 A) was enriched in a gene set that was previously 
shown to define a migratory DC phenotype in the mouse 
(Miller et al., 2012; Fig. 5 D). This further supports the DC 
origin of LCs and distinguishes them from macrophages in 
tissues. Thus, human LCs are enriched in pathways related to 
cross-presentation and migration compared with other exam-
ined human skin DCs.
LCs are superior at priming naive allogeneic  
CD8+ T Cells over dermal DCs
To test our observation related to the capacity of LCs to 
mediate class I–associated presentation, we tested the ability 
of the different human skin DC subsets to activate alloge-
neic naive CD8+ T cells (CCR7+CD45RA+CD45RO). As 
of human LCs to the well-established, cross-presenting human 
DC subset, blood CD141+ DCs. These cells have been previ-
ously shown to be equivalent to the mouse XCR1+CD8+ 
DC (Bachem et al., 2010; Crozat et al., 2010a; Jongbloed 
et al., 2010; Poulin et al., 2010). Using a recently published 
dataset where various blood DC subsets and monocytes were 
profiled, we identified a cluster of more than 200 transcripts 
that were differentially expressed between CD141+ DCs and 
all other blood DC subtypes (Haniffa et al., 2012; Fig. S2). 
Gene set enrichment analysis (GSEA; Subramanian et al., 
2005) was used to compute the similarity of each DC subset 
to blood CD141+ DCs relative to the other skin subpopula-
tions. GSEA is used to provide a statistical evaluation for the 
enrichment of a defined set of genes within a transcriptional 
profile. The gene set specific to the cross-presenting blood 
CD141+ DCs was analyzed against the transcriptional profiles 
of all the different skin DC subsets. Notably, LCs were the 
only human DC subsets that scored highly for the blood 
CD141+ DC-derived signature (Fig. 5 A; P < 103). This 
confirmed the similarity of LCs with an established cross- 
presenting DC subset. We performed a complementary analy-
sis by using the set of 200 of the LC-specific genes (Fig. S3 A) 
that were highly enriched in module Hu2 and then evaluated 
their enrichment within the blood CD141+ DC dataset. As 
Figure 4. Characterization of human epidermal and dermal DCs. (A) Flow cytometry analysis of isolated epidermal and dermal cells. Cells were 
gated on epidermal CD1ahi LCs, dermal CD1a(dim) or dermal CD14+ populations and analyzed for the expression of CD11b, CD11c, Langerin, CD24, Sirp, 
and BTLA. CD1ahiLangerin+ DCs that were found in the dermal suspension were excluded from this analysis. Representative phenotype of one out of five 
examined donors. (B and C) Gene expression analysis showing relative amounts of mRNAs expression of IL-15 (A) and Zbtb46 (B) by sorted skin DC sub-
sets: epidermal LCs, dermal CD1a(dim)CD141 DCs, CD1a(dim)CD141+ DCs, and CD14+ DCs isolated from at least three different specimens. Mean values ± 
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All skin DC subsets could present short peptide and induce 
IFN- by the CD8+ T cell clone (Fig. 7 A). However, only LCs 
and dermal CD1a(dim)CD141 DCs could cross-present the 
longer peptide to stimulate the CD8+ T cell clone (Fig. 7 B). 
LCs were more efficient than dermal CD1a(dim)CD141 DCs 
because as few as 250 cells were sufficient for stimulation 
(Fig. 7 B, light gray). This is consistent with the increased capac-
ity of LCs to pick up antigen (Fig. 7 C). As expected, both 
blood myeloid DC subsets (CD1c+ and CD141+ DCs) could 
present short peptide to the CD8+ T cell clone (Fig. 7 D), but 
only the CD141+ DCs were able to process long peptide and 
present it to CD8+ T cells (Fig. 7 E). The ability of blood 
CD141+ DCs to cross-present required DC activation and was 
enhanced by TLR3 and TLR7/8 ligation (Fig. 7 E).
To determine the capacity of the DC subsets to cross-
present external unprocessed antigens to naive CD8+ T cells, 
sorted LCs, and dermal DC subsets (dermal CD1a(dim)CD141+, 
CD1a+CD141, or CD14+ DCs) were incubated with recom-
binant MART-1 protein and cultured for 9 d with autologous 
naive CD8+ T cells and soluble CD40L. CD8+ T cells primed 
by LCs induced higher amounts of IFN- in response to re-
stimulation with MART-1–loaded DCs compared with CD8+ 
T cells primed by other skin DC subsets (Fig. 7 F). To mea-
sure the expansion of epitope-specific T cells, DCs from an 
HLA-A201+ donor were exposed to MART-121-35 peptide (YT-
TAEEAAGIGILTV) that contains the HLA-A201–restricted 
MART-1 decamer epitope (MART-126-35 EAAGIGILTV). Cells 
were cultured for 10 d with autologous CD8+ T cells puri-
fied from the donor skin (Fig. 7 G, top) or from the patient’s 
peripheral blood (Fig. 7 G, bottom). CD40L was added to ac-
tivate the DCs. As measured using a specific MHC-tetramer, 
LCs were the most effective at inducing the expansion of 
MART-126-35–specific CD8+ T cells compared with the other 
skin DC subsets (Fig. 7 G). Thus, LCs are highly adept for cross-
priming of soluble antigens to CD8+ T cells.
previously reported (Klechevsky et al., 2008; Banchereau et al., 
2012b), LCs are powerful stimulators of naive CD8+ T cell pro-
liferation, whereas dermal CD14+ DCs are weak in compari-
son. Dermal CD1a(dim)CD141 DCs were more efficient at 
priming allogeneic naive CD8+ T cells compared with the der-
mal CD1a(dim)CD141+ or to the dermal CD14+ DCs (Fig. 6, 
A and B). The response was dependent on the number of DCs 
present in the culture (Fig. 6 C). Activation of the Langerin+ 
DCs with TLR7/8 or TLR3-agonists did not result in a 
significant increase in CD8+ T cell proliferation (Fig. 6 D). 
Dermal CD14+ DCs barely induced any CD8+ T cell prolif-
eration, even after the maturation with TLR3 and TLR7/8 
agonist. Within the dermal CD1a(dim) DCs, CD141 DCs 
induced higher proliferation of naive CD8+ T cells com-
pared with CD141+ cells, particularly upon TLR7/8 activa-
tion (Fig. 6 D). In addition, cells cultured over LCs as well 
as dermal CD1a(dim)CD141 DCs induced allogeneic naive 
CD8+ T cells to secrete higher amounts of IFN- and express 
activation markers and effector molecules (CD25 and Granzyme 
B, respectively) compared with the dermal CD1a(dim)CD141+ 
and dermal CD14+ DCs (Fig. 6 E). Thus, LCs are powerful in-
ducers of naive CD8+ T cell proliferation and differentiation.
LCs efficiently cross-present and cross-prime  
antigens to CD8+ T cells
Finally, we examined the capacity of each DC subset to 
cross-present external unprocessed antigens to CD8+ T cells. 
Human LCs and dermal DC subsets (dermal CD1a(dim)CD141+, 
CD1a+CD141, or CD14+ DCs) from an HLA-A201+ donor 
were loaded with MART-121-35 peptide (YTTAEEAAGIGILTV) 
that contains the HLA-A201–restricted MART-1 decamer epi-
tope (MART-126-35 EAAGIGILTV) or with the short decamer 
epitope (MART-126-35 EAAGIGILTV). Cells were then washed 
and incubated with a CTL clone for 48 h. IFN- was measured 
in the culture supernatant by fluorescent bead array.
Figure 5. Enrichment of human LC-specific genes in  
different signatures as computed through GSEA. The GSEA 
algorithm for the enrichment of a specific gene signature in a 
gene expression dataset was performed. The genes are first ar-
ranged by expression level with the highest expressed genes on 
the left and the lowest expressed genes on the right. The posi-
tions of each of the genes in the “set” or “signature” is depicted 
by the black lines. The score is a running sum calculated by the 
expression level of each gene in the signature moving from left 
to right. (A) Human blood CD141+ DC specific signature among 
LC genes (P < 104). Human blood CD141+ DC specific signature 
was identified as top 200 genes specific for CD141+ DCs relative 
to other blood DC subtypes based on data from Haniffa et al., 
2012 (Fig. S2). (B) LC-specific gene signature (200 most LC- 
specific genes from module 2, which is enriched in cross- 
presentation pathway) is enriched in human blood CD141+ DCs 
(P < 104). (C) Genes from annotated antigen cross-presentation 
pathway (REACTOME; P < 104) and eight other annotated 
cross-presentation related pathways are also enriched in human 
LCs (Fig. S3 B). (D) Migratory DC signature defined by Immgen 
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et al., 2010b). In this study, we constructed a functional 
module strategy that takes into account the biological vari-
ability inherent to a specific DC subset (Fig. 1). Human systems 
immunology approaches have already been very powerful to 
study regulatory networks that underline immune processes 
(Amit et al., 2011; Buonaguro and Pulendran, 2011). Several 
DISCUSSION
Characterization of functionally distinct DC subsets in mice 
acquires special significance if analogous counterparts exist in 
humans. Unlike the lymphoid system of T and B cells, iden-
tifying equivalent DC subsets based on the expression of se-
lected surface receptors has proven to be inaccurate (Crozat 
Figure 6. LCs are more efficient than 
dermal DCs at priming allogeneic naive 
CD8+ T cells. (A) Proliferation of allogeneic 
naive CD8+ T cells primed with sorted skin LCs, 
dermal CD1a(dim)CD141 DCs, dermal 
CD1a(dim)CD141+ DCs, or dermal CD14+ DCs 
was measured after 6 d by the dilution of 
CFSE dye as analyzed by flow cytometry. His-
tograms show the percentage of proliferating 
(CFSElo) CD3+CD8+ T cells. Data are represen-
tative of eight independent experiments.  
(B) Graph shows the percentage of proliferat-
ing (CFSElo) CD3+CD8+ T cells in nine experi-
ments. (C) Graph shows the percentage of 
naive CD8+ T cell that diluted CFSE in re-
sponse to descending numbers of each DC 
subset that are present in the culture. Graph 
shows Mean ± SEM; n = 3. (D) Graph shows 
the percentage of naive CD8+ T cell that di-
luted CFSE in response to each DC subset that 
were activated with either CD40L, TLR3-agonist 
(Poly I:C), or TLR7/8-agonist (CLO75). Data  
are representative of three independent  
experiments. (E) Allogeneic CFSE-labeled naive 
CD8+ T cells were primed for 7 d by each skin 
mDC subset. The proliferating CFSElo cells 
were stained and analyzed by flow cytometry 
for the expression of the effector molecules 
IFN- and Granzyme B, as well as the activa-
tion marker CD25 upon restimualtion with 
PMA and Ionomycin. Data are representative 








niversity In St. Louis Libraries user on 07 D
ecem
ber 2019
752 Conservation of mouse and human DCs | Artyomov et al.
Figure 7. LCs Are highly efficient at cross-presenting and cross-priming antigens to CD8+ T cells. (A) Skin DC subsets (LCs, dermal 
CD1a(dim)CD141, CD1a(dim)CD141+, and dermal CD14(dim) DCs) from an HLA-A201+ donor were loaded with 10 aa HLA-A201-MART-1–restricted epitope 
and cultured with a specific CD8+ T cell clone. Graph shows the amounts of IFN- that were measured in the culture supernatant after 48 h by Luminex. 
One representative experiment out of three performed. (B) Skin DC subsets (LCs, dermal CD1a(dim)CD141, CD1a+CD141+, and dermal CD14+ DCs) from an 
HLA-A201+ donor were loaded with 15 aa MART-1 peptide containing the HLA-A201–restricted epitope and cultured with MART-1–specific CD8+ T cell 
clone. Graph shows the amounts of IFN- that were measured in the culture supernatant after 48 h. One representative experiment out of three per-








niversity In St. Louis Libraries user on 07 D
ecem
ber 2019
JEM Vol. 212, No. 5
Article
753
T cells, rather than T regulatory (T reg) cells in the skin upon 
activation (Seneschal et al., 2012). Although in the human 
these DCs play a critical role in immunity, the relevance of 
LCs to CD8+ T cell–mediated immunity in mice is still dis-
puted. In particular, mouse LCs were shown to be dispens-
able over the dermal Langerin+CD103+ DCs for inducing 
CD8+ T cell responses in several viral infection, tumor, and 
self-antigen models (Igyártó et al., 2011; Kautz-Neu et al., 
2011; Gomez de Agüero et al., 2012), whereas in other cases 
they were found to be essential for protective immunity 
(Sparber et al., 2010; Liard et al., 2012; Wang et al., 2012). 
The identification of two different types of mouse LCs 
(Seré et al., 2012) may be important in the interpretation of 
these studies.
Although this is not the case in mice, the only skin DC 
subset that expresses Langerin in humans are the Langer-
hans cells of the epidermis. The best indication is that no 
Langerin-expressing cells could be detected in the dermis by 
immunofluorescence staining of human skin tissue (Fig. 3 D). 
However, occasionally a small proportion (1%) of Langerin+ 
cells were found in the dermal cell suspension (Fig. S1 A, 
gate II). Because these cells expressed higher amounts of 
CD1a compared with the intermediate dermal CD1a popu-
lation (Fig. S1 C) and they also expressed EpCam, we sur-
mised that they were likely to represent LCs that migrate 
through the dermis, as proposed for a similar population that 
was observed in the mouse (Nagao et al., 2009). Alterna-
tively, they may simply be residues of LCs of the epidermis 
that remain after its separation from the dermis. Because these 
cells were too rare to study and we also could not exclude the 
fact that these might be contaminating LCs, we excluded 
them from the current analysis.
Previously identified differences between mouse and 
human LCs may, however, further help explain the discrep-
ancy between the two species. For example, in the mouse, 
LCs resemble tissue-resident macrophages; they are develop-
mentally dependent on M-CSFR (Ginhoux et al., 2006; 
Wang et al., 2012), express macrophage-specific markers 
such as F4/80 and CD11b, migrate poorly to lymph nodes 
relative to the migration of conventional DCs to lymph 
nodes, constitutively secrete IL-10 (Igyarto et al., 2009), and 
major advantages of transcriptional co-expression networks 
make such studies a future step in the genomic understanding 
of the relationship between mouse and human DCs. First, 
transcriptional network analysis is less dependent on the mag-
nitude of change in expression of any individual gene. Network 
analysis elucidates connections between genes and pathways 
to be revealed that might otherwise have been unappreciated 
(Han et al., 2004a). Second, network analysis reveals genes 
and pathways that are predicted to be central to the biological 
system being analyzed (Jeong et al., 2001). Finally, network 
analysis identifies modules of highly correlated genes repre-
senting transcriptional developmental programs that can serve 
as comparative factors in determining human mouse ana-
logues. Transcriptional co-expression networks may thus fa-
cilitate a deeper understanding of complex cellular systems.
Using this method, we found that human skin DCs share 
key transcriptional modules with mouse DCs. Specifically, 
the human dermal CD14+ DCs displayed functional similari-
ties with the mouse CD103CD11b+ DCs that was related 
to MDA and RIGI type I IFN induction and signaling, sug-
gesting that dermal CD14+ DCs might be an important initial 
source of type I IFN production in response to a viral inva-
sion on the skin, even before the migration of plasmacytoid 
DCs (pDCs) to the skin.
We also found that human LCs displayed functional simi-
larities with the mouse CD8+ DC subsets that co-expressed 
CD103 and the chemokine receptor XCR1. These cells in-
clude the mouse thymic and small intestine DCs. Interest-
ingly, both mouse thymic DCs and a unique CD8+CD103+ 
small-intestine DCs were particularly efficient at priming 
T cell responses (Dresch et al., 2011; Fujimoto et al., 2011). 
Functionally, human LCs were the most adept at priming 
allogeneic naive CD8+ T cells into effector CTLs compared 
with the other skin populations. They were also highly effec-
tive at cross-priming soluble antigens to syngeneic naive CD8+ 
T cells.
LCs have long been considered to be the major sensitizing 
cells in the skin by initiating protective immunity in naive rest-
ing T cells. A role in allergic hypersensitivity was first reported 
in humans and guinea pigs (Silberberg et al., 1976). They were 
shown to effectively expand pathogen-specific effector CD8+ 
at conc. 1 mg/ml at either 4°C or 37°C. The uptake was measured by the amount of FITC fluorescence in the cells after 30 or 90 min by flow cytometry. 
Cells that were not exposed to beads served as an additional control. (right) Histograms show FITC uptake by the different DC subsets at 30 min. (left) 
Graph shows FITC geometric mean as measured for the different skin DC subsets after 30 and 90 min. One representative experiments of three per-
formed. (D) Blood DC subsets (CD1c+ and CD141+) from an HLA-A201+ donor were loaded with 10 aa HLA-A201-MART-1–restricted epitope and cul-
tured with a specific CD8+ T cell clone. Graph shows the amounts of IFN- that were measured in the culture supernatant after 48h by Luminex. One 
representative experiments out of three performed. (E) Blood DC subsets (CD1c+ and CD141+) from an HLA-A201+ donor were loaded with 15 aa MART-1 
peptide containing the HLA-A201–restricted epitope and cultured with MART-1–specific CD8+ T cell clone. Graph shows the amounts of IFN- that were 
measured in the culture supernatant after 48 h. One representative experiment out of three performed. (F) To assess cross-priming, skin DC subsets were 
incubated with a MART-1 protein and autologous naive CD8+ T cells. After 9 d, IFN-–producing CD8+ T cells were assessed by flow cytometry upon 
restimulation with fresh MART-1–loaded DCs. (Graph shows mean ± SEM; n = 3). (G, top) To assess the cross-priming of a specific MART-1 CD8+ T cell 
epitope, skin DC subsets (LCs, dermal CD1a(dim)CD141, CD1a(dim)CD141+, and dermal CD14+ DCs) from an HLA-A201+ donor were incubated with 15 aa 
MART-1 peptide containing the HLA-A201–restricted epitope and with autologous purified CD8+ T cells for the donor’s skin. After 10 d, the number of 
MART-1–specific CD8+ T cells was determined by the binding of a specific tetramer. (bottom) Similar to the top, except that CD8+ T cells were purified 
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In the mouse, early cells of the CD8+ DC lineage are 
not initially able to cross-present antigens, rather this ca-
pability is induced as a later developmental step via TLR 
ligation or exposure to GM-CSF. Similarly, it was shown 
that the capacity of human blood CD141+ DCs to cross-
present is dependent on TLR ligands such as poly I:C 
(Fig. 7 D; Haniffa et al., 2012). In that respect, human blood 
CD141+ DCs could represent the equivalent of an earlier 
CD8 lineage DCs in mice, where additional factors are 
also needed to induce the ability to cross-present antigens. 
Human blood-originated dermal CD141+CD11c cells 
were reported to require TLR activation for efficient cross-
presentation (Haniffa et al., 2012). The ability to cross-prime 
antigen to naive T cells without a requirement of a TLR 
activation is thought to be a unique property of thymic 
DCs (Dresch et al., 2011). Here, we show that LCs display 
a similar capacity and efficient cross-priming could be dem-
onstrated in the absence of TLR stimulation (Fig. 7). This 
is consistent with our data showing their transcriptional 
similarity to thymic DCs. Consistent with that, LCs express a 
very limited set of TLRs as previously reported (Flacher et al., 
2006; Klechevsky et al., 2009).
In summary, our study highlights novel functional simi-
larities between human and mouse DC systems. Most pro-
foundly, between the dermal CD14+ DCs and the mouse 
CD11b+CD103 and between human epidermal LCs and 
the mouse XCR1+CD8+CD103+ DCs. Surprisingly, al-
though mouse and human LCs share some of their markers 
and their physical location of the epidermis, they differ in 
their functional module gene expression, which may in fact 
be more relevant for experimental modules. Overall, our 
findings demonstrate that human but not mouse LCs are 
enriched in cross-presentation–specific models. Thus, pro-
viding further insight as to the role of LCs in human as 
cross-presenters of soluble antigens and efficient activators of 
CD8+ T cells.
MATERIALS AND METHODS
Isolation of skin DC subsets. Human skin specimens were obtained from 
donors who underwent cosmetic surgeries at Washington University School 
of Medicine (St. Louis, MO) and Barnes Jewish Hospital (St. Louis, MO) in 
accordance with Institutional Review Board guidelines. LCs, CD1a(dim), and 
CD14+ dermal DCs were purified from normal human skin. Specimens 
were incubated with the bacterial protease, dispase type 2, for 18 h at 4°C. 
Epidermal and dermal sheets were separated and placed in RPMI 1640 sup-
plemented with 10% fetal bovine serum. After 2 d, the cells that migrated 
into the medium were enriched using a Ficoll-diatrizoate gradient. DCs 
were purified by cell sorting after staining with anti-CD1a FITC and anti-
CD14 APC mAbs. CD40L (200 ng/ml; R&D Systems) or TLR3 (poly I:C; 
10 µg/ml), TLR4 (LPS; 25 ng/ml), and TLR7/8 (CLO75; 1 µg/ml) ago-
nists were used to activate the cells as indicated.
Microarray data acquisition and processing. RNA from sorted popula-
tions was purified using TRIzol. RNA was processed, amplified, labeled, 
and hybridized at Washington University Core Facility (GTAC) with Illu-
mina HumanHT-12 v4 Expression BeadChip. Data were background sub-
tracted and quantile normalized. Normalized mouse DC Immgen dataset was 
downloaded from the official website.
have little to no expression of Zbtb46. This suggests a macro-
phage identity rather than a DC identity (Meredith et al., 2012; 
Satpathy et al., 2012). On the contrary, human LCs do not 
express any of the macrophage markers, they are negative for 
CD11b, express IL-15 (Klechevsky et al., 2008; Banchereau 
et al., 2012a) and Zbtb46 (Fig. S4, B and C). This supports 
their DC identity, and is consistent with their capacity to prime 
T cells. Contrary to this, human LCs display similar markers to 
the mouse CD8+/CD103+ DCs, including BTLA and CD24. 
Although human LCs lacked the expression of XCR1 (Fig. 4 A), 
a marker on a mouse cross-presenting DC subset, they were 
highly enriched in functional modules shared with the mouse 
XCR1 populations. This further extenuating the lack of sig-
nificance in using individual markers as a correlative factors in 
determining human/mouse analogues. Overall, the expression 
of XCR1 on dermal CD1a(dim)CD141+ DCs and on dermal 
CD14+, but not on LCs or dermal CD1a(dim)CD141 further 
suggests that XCR1 may not faithfully mark the cross-presenting 
DC subset in human.
Although in blood, CD141 marks a small population of 
cross-presenting DC subset (Jongbloed et al., 2010), in human 
skin, CD141 is detected on multiple populations, including 
on a small subset of the dermal CD1a(dim) DCs and on the 
dermal CD14+ DCs (Chu et al., 2012; Haniffa et al., 2012), 
but not on LCs. Thus, similar to XCR1, CD141 on its own 
may not be sufficient to mark a cross-presenting tissue DC 
subset. Overall, systemic genomic comparison, as we have done 
for all four human skin DC populations, and ensuing func-
tional comparison is the most reliable approach to determine 
such homologies.
Our study shows that LCs are enriched in genes related 
to the cross-presentation pathway. Interestingly, we found 
that this set of genes is enriched in the blood CD141+  
DCs gene transcript, the proposed equivalent to the mouse 
CD8+ DCs (Bachem et al., 2010; Crozat et al., 2010a), 
but not in other examined blood antigen-presenting cells. 
In a different analysis we showed that blood CD141+ DC-
specific signature is enriched in LCs and not other skin 
DC subsets. This suggests that CD141+ DCs, LCs and the 
CD8+ DCs share a common transcriptional signature as-
sociated with cross-presentation. Although human blood 
CD141+ DCs are considered the cross-presenting gold stan-
dard and the mouse CD8+ DC homologue, Cohn et al., 
recently showed that receptor mediated delivery of antigen 
could facilitate cross-presentation in blood CD1c+ DCs 
(Cohn et al., 2013). Because we tested only soluble anti-
gen, we suspect that the cross-presentation signature is re-
quired for soluble antigen cross-presentation and not antigen 
directed into early endosomes. In addition, Segura et al. 
showed that CD1c+ DCs isolated from tonsils cross-present 
as efficiently as tonsil CD141+ DCs (Segura et al., 2013). 
Taken the differences observed between skin CD141+ DCs 
and blood CD141+ DCs, we suspect that tissue CD141+ 
DCs are different from blood. Overall, CD141 may also 
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by the level of cell tracer carboxyfluorescein succinimidyl ester 
(CFSE) dilution at the end of the culture. IFN- production (BD) was 
assessed by flow cytometry after an additional 5-h stimulation with PMA 
(25 ng/ml; Sigma-Aldrich) and ionomycin (1 µM; Sigma-Aldrich). For 
autologous cross-priming responses, CD8+ T cells (1 ×105 cells/well) 
were stimulated with autologous skin DC subsets (2.5 × 104 cells/well) 
that were incubated with the MART-1 protein or 15 aa MART-121-35 
peptide (YTTAEEAAGIGILTV). Cells were cultured for 9 d in with 
10 U/ml IL-7 (R&D Systems) and 100 ng/ml CD40L (R&D Systems). 
IL-2 was added at 10 U/ml at day three. Cross-priming was assessed 
by the expansion of specific CTLs binding a specific HLA-A201+ tetramer. 
For intracellular cytokine analysis, day seven-primed CD8+ T cells were 
restimulated for six hours with antigen-loaded fresh DCs in fresh medium 
containing CD40L. Surface CD25 expression and intracellular IFN- 
and Granzyme B (all from BD) were assessed by flow cytometry. 
Cytokines in the culture supernatant of CFSEloCD11cCD4CD8+  
T cells (1.5 × 105 cells per ml) were measured using a multiplex bead 
assay Luminex after 48 h of restimulation with anti-CD3 and anti-CD28 
mAbs. For the cross-presentation assay, sorted HLA-A201+ skin or 
blood DC subsets were incubated (2,500 cells/well) in U-bottom 96-
well plates with 1 µM 15 aa MART-1 peptide (YTTAEEAAGIGILTV) 
or Mart-1 short peptide (ELAGIGILTV) or without peptide for 3 h in 
RPMI medium. After extensive washing, DCs were cultured with 
MelanA–specific CD8+ T cell clone (20,000 cells) in RPMI medium 
supplemented with 10% human serum. Supernatants were collected and 
analyzed for IFN- concentration by Luminex. DC activation was added 
as indicated.
Accession no. Microarray dataset is available through Gene Expression 
Omnibus under accession no. GSE66355.
Online supplemental material. Fig. S1 shows the gating strategy and 
description of dermal DC populations in the skin. Fig. S2 shows the human 
blood CD141 DC-specific gene signature as derived compared with the 
other blood APCs. Fig. S3 shows human LC-specific gene signature as de-
rived compared with the other skin DC subsets and enrichment of vari-
ous expression signatures in skin epidermal LCs relative to other skin DC 
subtypes. Table S1, available as an Excel file, lists the genes that comprise 
each of the 16 mouse modules. Table S2, available as an Excel file, lists the 
genes that comprise each of the 9 human modules. Table S3, available as 
an Excel file, shows the cross-presenting gene signature list of 311 genes 
that are shared between mouse module (Mm)1 and human module (Hu)2. 
Table S4, available as an Excel file,lists the genes that are shared between 
the mouse (CD103+CD8+) and human (LCs) cross-presenting DC subsets. 
Table S5, available as an Excel file, lists the REACTOME annotated 76 and 
48 genes that belong to the antigen processing and cross-presentation, and 
the cross-presentation of soluble exogenous antigens endosomes pathways, 
respectively. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20131675/DC1.
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Gene co-expression network analysis. To address the functional rela-
tionship between DCs in mouse and human we assembled two com-
prehensive datasets: a murine DC dataset that contains 36 different DC 
subpopulations (3–4 replicates per subtype) derived from the Immgen Data-
base of mouse immune cells and a human skin DC dataset that spanned 4 
major skin-resident DC subpopulations from multiple human donors. For 
the human skin DC dataset, only genes with an average expression value 
greater than 150 were kept, amounting to 6134 genes. Modules were identi-
fied using weighted gene co-expression network analysis (WGCNA) R 
package (Langfelder and Horvath, 2008). We used Pearson’s correlation co-
efficient as metrics with a power parameter of 12, determined as the power 
at which scale-free characteristics of the network reached a plateau. Addi-
tional parameters were minModuleSize = 100, reassignThreshold = 0.2, 
mergeCutHeight = 0.1, maxBlockSize = 10,000, deepSplit = 2. Genes with 
average expression >150 were kept, amounting to 8,059 genes. For module 
identification, WGCNA algorithm was used with a power parameter of 10. 
To compute the statistical significance of overlap between modules we used 
Fisher’s exact test.
The GSEA algorithm was performed as previously described (Subramanian 
et al., 2005). In brief, to test for the enrichment of a specific gene signature 
in a gene expression dataset, the genes are first arranged by expression level 
with the highest expressed genes on the left and the lowest expressed genes 
on the right. The positions of each of the genes in the “set” or “signature” 
are depicted by the black lines. The score is a running sum calculated 
by the expression level of each gene in the signature moving from left 
to right.
Skin DC analysis by immunofluorescence. Skin specimens were em-
bedded in OCT and frozen. 5-µm sections were cut using the Leica CM 
1950. For immunofluorescent staining, tissue sections were fixed in 4% PFA 
for 10 min at room temperature and washed with PBS containing 3% BSA 
and 10% saponin. Sections were quenched with 0.5 M Glycine for 5 min, 
washed, and blocked with PBS/BSA/Sapo for 30 min at room temperature. 
Tissue sections were incubated overnight at 4°C with either polyclonal rab-
bit anti–human antibodies, PSME1 (2.5 µg/ml; Novus Biologicals), Sec61a 
(0.5 µg/ml; Pierce Antibodies), TAP2 (2 µg/ml; LifeSpan BioScience) or an 
isotype control. All sections were stained for mouse anti–human Langerin 
(CD207; 2 µg/ml; Beckman Coulter) overnight at 4°C. Sections were then 
washed and incubated with anti–mouse Alexa Fluor 488 (1/200) and donkey 
anti–rabbit Alexa Fluor 647 (0.6 µg/ml; Jackson ImmunoResearch Labo-
ratories) for 2 h followed by 4’,6’-diamidino-2-phénylindole (DAPI) for 
10 min at room temperature. Sections were then washed in PBS and 
mounted (Invitrogen). Images were acquired using an Olympus Confocal 
Microscope FV1000 using Fluoview software. Image analysis was performed 
using ImageJ software.
Statistical analyses. Two-sample Student’s t test was used to calculate differ-
entially expressed genes. For cell-specific signatures, the top 200 up-regulated 
genes were taken. Mouse to human orthology mapping was performed with 
the biomaRt R package (Durinck et al., 2005, 2009). For pathway analysis, we 
used the GSEA (Subramanian et al., 2005) and MSigDb (Broad Institute).
Antigen uptake. Epidermal or dermal DCs were cultured at 37°C with or 
without FITC-labeled 40KDa dextran (Nanocs Inc.). After 30 or 90 min, 
cells were harvested and washed with cold media. They were then stained 
for DC markers and analyzed by flow cytometry. The intensity of the FITC 
signal was determined for each DC subset. Cells cultured with FITC-
dextran at 4°C served as an additional control.
DC/T cell co-cultures. Naive CD8+ T cells were sorted as CD45RA+ 
CCR7+HLA-DRCD8+ cells. Allogeneic primed CD8+ T cells were 
characterized for the expression of the cytotoxic effector molecules Gran-
zyme B (Molecular Probes) and activation molecule CD25 (BD) after 7 d 
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